CY2340B1 - Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa. - Google Patents

Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa.

Info

Publication number
CY2340B1
CY2340B1 CY0300027A CY0300027A CY2340B1 CY 2340 B1 CY2340 B1 CY 2340B1 CY 0300027 A CY0300027 A CY 0300027A CY 0300027 A CY0300027 A CY 0300027A CY 2340 B1 CY2340 B1 CY 2340B1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical preparations
targeted treatment
colitis ulcerosa
morbus crohn
morbus
Prior art date
Application number
CY0300027A
Other languages
English (en)
Inventor
Ulrich Posanski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY2340B1 publication Critical patent/CY2340B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY0300027A 1993-09-01 2003-03-18 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa. CY2340B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4329503A DE4329503A1 (de) 1993-09-01 1993-09-01 Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa

Publications (1)

Publication Number Publication Date
CY2340B1 true CY2340B1 (en) 2004-02-06

Family

ID=6496579

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300027A CY2340B1 (en) 1993-09-01 2003-03-18 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa.

Country Status (12)

Country Link
EP (2) EP0716598B1 (xx)
JP (1) JP3712005B2 (xx)
AT (1) ATE207743T1 (xx)
AU (1) AU693470B2 (xx)
CA (1) CA2170748C (xx)
CY (1) CY2340B1 (xx)
DE (2) DE4329503A1 (xx)
DK (1) DK0716598T3 (xx)
ES (1) ES2166781T3 (xx)
NZ (1) NZ271655A (xx)
PT (1) PT716598E (xx)
WO (1) WO1995006464A1 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DK0673646T3 (da) * 1994-03-22 1999-08-16 Nippon Kayaku Kk Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
GB2303550B (en) * 1994-06-21 1998-07-08 Danbiosyst Uk Colonic drug delivery system
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
WO1998046268A1 (fr) * 1997-04-11 1998-10-22 Fujisawa Pharmaceutical Co., Ltd. Composition medicamenteuse
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
SI1064942T1 (en) 1998-03-26 2004-12-31 Fujisawa Pharmaceutical Co., Ltd. Sustained release preparation of a macrolide
AUPP584198A0 (en) 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
KR100695562B1 (ko) * 1998-09-28 2007-03-15 워너-램버트 캄파니 엘엘씨 Ｈｐｍｃ 캡슐을 이용한 장 및 결장에의 전달방법
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
GB0525546D0 (en) * 2005-12-15 2006-01-25 Novartis Ag Organic compounds
CN103120653B (zh) 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
FR2933871B1 (fr) * 2008-07-18 2012-12-14 Yvery Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
WO2010122574A2 (en) * 2009-04-20 2010-10-28 Sun Pharma Advanced Research Company Ltd. Coated capsule
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物
EP3787606A1 (en) * 2018-05-03 2021-03-10 M W Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
BE895724A (fr) * 1982-02-01 1983-07-28 Sandoz Sa Nouvelle utilisation therapeutique de la dihydrocyclosporine d
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JPH0211514A (ja) * 1988-06-30 1990-01-16 Takara Shuzo Co Ltd スパガリン類製剤
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments

Also Published As

Publication number Publication date
CA2170748C (en) 2008-10-28
WO1995006464A1 (de) 1995-03-09
ES2166781T3 (es) 2002-05-01
ATE207743T1 (de) 2001-11-15
NZ271655A (en) 1997-09-22
EP1110545A2 (de) 2001-06-27
DE59409929D1 (de) 2001-12-06
DE4329503A1 (de) 1995-03-02
EP0716598B1 (de) 2001-10-31
JPH09501939A (ja) 1997-02-25
EP0716598A1 (de) 1996-06-19
PT716598E (pt) 2002-04-29
EP1110545A3 (de) 2001-07-04
CA2170748A1 (en) 1995-03-09
AU7535494A (en) 1995-03-22
AU693470B2 (en) 1998-07-02
DK0716598T3 (da) 2002-02-18
JP3712005B2 (ja) 2005-11-02

Similar Documents

Publication Publication Date Title
CY2340B1 (en) Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa.
ATE154237T1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
EP0676974A4 (en) RETENTION AND SEALING SYSTEM FOR A CONDUCTOR FOR AN IMPLANTABLE MEDICAL DEVICE.
AU2698684A (en) Polypeptide biodegradable et son utilisation pour le relargage progressif de medicaments
ATE203161T1 (de) Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
AR243375A1 (es) Preparacion farmaceutica, capsula de gelatina con revestimiento enterico. procedimiento y aparato.
NO911260D0 (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
GEP19981426B (en) Container in the Form of Joint Toy
NO900395D0 (no) Fremgangsmaate og apparat for oppbevaring og transport av gassformete stoffer.
AU7250491A (en) Sterilization and coating apparatus
AU7655691A (en) Grain supplying vessel, grain containing body, and grain assemblage
CA2176258A1 (en) Device and method for photoactivation
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
ATE149827T1 (de) Feste arzneimitteldosierungsform und methode zur verminderung des abriebs
GEP20022629B (en) Sustained-Release Microgranules Containing Diltiazem As The Active Principle and Gelatinous Capsule Containing the Same
GR3008170T3 (xx)
RU96118929A (ru) Способ повышения защитных свойств организма при воздействии внешних физических факторов
AU668767B2 (en) Oral medicament form
CA2082270A1 (en) Anti-viral therapy
EP0278467A3 (en) Use of oxoquinazoline derivatives in the treatment of hyperuricemia
NO911296L (no) Fremgangsmaate og apparat for graving av groefter.
CA2205013A1 (en) A method and a device for application of powder on a strip
EP0676206A4 (xx)
NZ232499A (en) Pharmaceutical composition comprising 5-(2-chloro-ethyl)-4-methylthiazole
EP0357072A3 (en) Use of zofenopril for the preparation of drugs against rheumatoid arthritis